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ABSTRACT
SMOOTH MUSCLE CELL ORGANIZATION IN THE STEM REGION OF THE GRACILIS
COLLATERAL CIRCULATION
Amanda Krall

Many patients who suffer from the ischemic Peripheral Arterial Occlusive Disease
(PAOD) experience intermittent claudication, which can be attributed to impaired
vasodilation. Collateral vessels are the primary site of resistance to blood flow
downstream; therefore maximizing vasodilation in collaterals is crucial for efficient
circulation. Collaterals function as natural bypasses around the occluded arteries
and the increase in flow into these vessels causes them to outwardly remodel into
conduit vessels. However, functional vasodilation in the stem region of collateral
vessels is impaired at day 7 following femoral ligation, which can be attributed to
smooth muscle cell malfunction. However, the increase in vessel diameter in
outwardly remodeled collaterals is not due to cell proliferation. One possible
explanation for the diameter increase in the stem region of the collateral is that the
vascular smooth muscle cells undergo mechanoadaptation to acclimate to the
increase in blood flow and fluid shear stress. To test this hypothesis, outward
remodeling was induced in the gracilis collateral stem via femoral artery ligation. At
day 7 following surgery, maximal vasodilation in the profunda femoris artery
(collateral stem) was evaluated before perfusion fixation. The profunda was then
resected and immunostained before measuring smooth muscle cell length and
overlap using confocal microscopy. Average SMC overlap was significantly less in
the collateral artery, 43 ± 1 μm versus 51 ± 2 μm in the control artery. Also, average
SMC length was significantly longer in the collateral artery 249 ± 13 μm versus 205
± 10 μm in the control. These results indicate that mechanoadaptation occurred in
the collateral stem and its correlation to impaired vasodilation suggests that the
reorientation and remodeling associated with mechanoadaptation may play a causal
role in vessel impairment. Further studies need to be performed to determine if
mechanoadaptation causes impaired vasodilation for patients with PAOD.
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INTRODUCTION
Peripheral Arterial Occlusive Disease
Peripheral Arterial Occlusive Disease (PAOD) affects 12 million Americans,
and disease prevalence increases with age [1]. PAOD is characterized by the
narrowing of arteries due to atherosclerotic plaque accumulation in the lower
extremities and is a strong predictor for coronary heart disease. These obstructions
can lead to ischemia, or an insufficient blood supply. Subsequently, there is an
inadequate amount of oxygen and glucose required for metabolic function in the
peripheral tissues [2].

Figure 1: Peripheral Arterial Occlusive Disease. Narrowed arteries and reduced
blood flow due to plaque buildup that causes PAOD [3].
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Intermittent claudication, which is pain caused by deficient blood flow
during exercise, is the result of ischemia and is the primary symptom of patients
diagnosed with PAOD. For these individuals, pain occurs during increased activity
and is alleviated during rest; however, if left untreated, the disease can progress to
Critical Limb Ischemia (CLI), a very severe form of PAOD characterized by chronic
ischemic pain at rest [4]. Risk factors for PAOD include age, obesity, cigarette
smoking, diabetes mellitus, physical inactivity, high blood pressure, and high
cholesterol. Patients who have PAOD experience a lower the quality of life because
they must constantly endure uncomfortable physical pain during daily activity [2].
Current Treatment Methods for Patients with PAOD
The effectiveness of current treatment options for PAOD is limited. The first
step following diagnosis is lifestyle changes, such as increasing exercise and eating a
balanced, healthy diet. Other treatment options include medications that prevent
blood clots, lower cholesterol, or relieve symptoms to improve claudication [5].
Often these drugs are palliative, and alleviate the primary symptoms but do not
treat the underlying issue of impaired vasodilation. In more severe cases,
angioplasty or bypass surgery may be performed. Angioplasty is a minimally
invasive procedure that involves placing a balloon catheter at the blockage site and
inflating it to widen the artery. In many cases a stent is deployed in the artery to
ensure that the vessel remains patent. During this procedure, the stent is mounted
onto the balloon and when the balloon expands, the stent is compressed against the
arterial wall. The balloon is then deflated and removed while the stent remains in its
position (Figure 2). Stenting generally provides immediate relief; however, the
8

vessel can undergo restenosis, or the reduction in the lumen diameter following
stent intervention [6]. Bypass surgery is performed to circumvent an occlusion by
surgically anastomosing a vein graft proximal and distal to the site of occlusion, as
an alternative route for blood flow around the blocked artery. As with any surgical
procedure there are risks associated with bypass surgery and eventually graft
occlusion can occur, which causes a recurrence of ischemia [7].

Figure 2: Angioplasty and Stent Deployment. A balloon catheter is guided to the
blockage site and inflated to widen the artery. A stent is left behind at the blockage
site to keep the affected vessel open [8].

Due to the limitations of the current intervention methods, an alternative
therapy is desired. Establishing a better understanding of the body’s natural
physiologic response to an arterial occlusion may be beneficial in developing an
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effective treatment for patients with PAOD. When an arterial occlusion restricts
blood flow, blood is redirected down alternative pathways via collateral vessels,
pre-existing arterial-arterial connections, which can act as natural bypass routes
around occlusions. The pressure is lowered downstream of an occlusion, which
increases blood flow and pressure in the collateral network. The increased blood
flow increases the fluid shear stress along the wall of collateral vessels and
stimulates arteriogenesis, the outward remodeling of collateral vessels [9].
Arteriogenesis in Collaterals
Arteriogenesis begins when the endothelial cells that line the luminal surface
in the collateral vessel are activated in response to the increase in fluid shear stress.
The endothelial cells display adhesion proteins and express monocyte
chemoattractant protein-1 (MCP-1) on their surface to recruit monocytes to adhere
to the endothelium. The monocytes extravasate and become macrophages that
secrete matrix-metalloproteinases (MMPs), which degrade the matrix to allow the
collateral to be remodeled [10]. Concomitantly, the endothelial cells secrete vascular
endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α) to cause
endothelial cell and vascular smooth muscle cell (SMCs) proliferation, respectively
[11]. This process enlarges the lumen diameter until the shear stress is normalized.
Arteriogenesis is most often described in the mid-zone of the collateral
circuit, however the SMC proliferation that is characteristic of arteriogenesis is
absent from the stem region of the collateral circuit, despite an increase in resting
diameter that is suggestive of outward remodeling. The increased resting diameter
of the stem region in the absence of SMC proliferation may be explained by SMC
10

mechanoadaptation, the rearrangement of SMCs through changing cell length and
cell overlap without proliferation to chronically resize the lumen diameter.

Figure 3: Arteriogenesis. Progression of arteriogenesis, the outward remodeling of
collateral vessels, from normal blood flow (left) to altered blood flow due to
occlusion (right) [12].

Impaired Vasodilation
Impaired vasodilation, which is observed in patients with PAOD, is a possible
explanation for intermittent claudication because sufficient vasodilation is
imperative for supplying adequate blood flow and nutrients to meet tissue
metabolic demand, especially during periods of physical exertion [13]. It is also
known that during muscle contraction arterioles vasodilate to increase blood flow
to tissues [14]. If vasodilation was impaired this could result in inadequate nutrient
delivery and thus pain to the extremities. Impaired vasodilation is observed in
patients with PAOD, therefore it is useful to further study this phenomenon [15].
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It was previously hypothesized that SMC proliferation during arteriogenesis
was the cause of impaired vasodilation. During the outward remodeling process,
SMCs change phenotype from contractile to synthetic since the synthetic phenotype
is more proliferative. This results in an increase in number of SMC cells with noncontractile function, which would enlarge the diameter, but may impair the vessel’s
reactivity [16]. However, proliferation was not observed in the collateral stem and
could not be a cause of impairment, therefore SMC mechanoadaptation has been
considered. Changing of SMC length and overlap causes substantial structural
changes to the cell components, which may have debilitating effects on cell
contraction and relaxation.
Previous Work
Resting diameter of the profunda femoris artery (stem to the gracilis
collateral circuit) is increased at day-7 following femoral artery occlusion, however
the percent change from resting to maximally dilated diameter is reduced, which
indicated a decreased dynamic range in the vessel. There is also an increase in blood
flow in the profunda femoris artery at day-7. Also at day 7 in the occluded hindlimb,
smooth muscle-dependent vasodilation is significantly impaired in the profunda
femoris artery [17]. Surprisingly the proliferation of SMCs did not occur in the
profunda femoris artery following femoral ligation and there was no significant
difference in the number of SMCs between the ligated and non-ligated hindlimbs,
indicating that the increase in vessel diameter was not due to cell proliferation. This
suggests that the cause of the impairment of the collateral stem needs to be studied
further [16].
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Given the absence of SMC proliferation, mechanoadaptation has been further
investigated. SMCs in rat arterioles undergo mechanoadaptation in response to
prolonged exposure to the vasoconstrictor norepinephrine (NE). The vessels
showed a decrease in vessel diameter as well as an increase in SMC overlap,
indicating that the SMCs mechanically reoriented themselves to acclimate to the
change in their environment and cause remodeling of the vascular wall (Figure 4)
[18]. Mechanoadaptation can work in the opposite direction and may cause an
increase in lumen diameter through an increase in SMC length and a decrease in
SMC overlap.

Figure 4: Mechanoadaptation in Rat Arterioles. Study investigated by MartinezLemus et al. showed an increase in SMC overlap when rat arterioles were exposed to
vasoconstrictors for extended periods of time [18].

Specific Aims
Patients with PAOD experience intermittent claudication, which may be
explained by impaired vasodilation of the collateral network. Impaired vasodilation
13

cannot be explained by SMC proliferation; therefore SMC mechanoadaptation and its
role in vessel impairment must be further studied. The objectives of this study were
to:
1. Test the hypothesis that the collateral stem undergoes outward
remodeling by comparing resting diameter to papaverine and SNP
induced maximal vasodilation
2. Test the hypothesis that the outward remodeling that occurs can be
explained by smooth muscle cell mechanoadaptation
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MATERIALS AND METHODS
Animal Husbandry
Male C57BL/6 mice were used for all procedures according to experimental
protocols that were approved by the Institutional Animal Care and Use Committee
(IACUC) of California Polytechnic State University. The mice were housed in the Cal
Poly vivarium in micro-isolator cages within a temperature controlled room on a 12
hour light-dark cycle. Mice were monitored daily and were provided with
enrichment, and feed and water ad libitum.
Femoral Artery Ligation Surgery
An arterial occlusion was simulated in the mouse hindlimb via femoral artery
ligation. Prior to surgery, the instruments and materials were sterilized in an
autoclave and the surgery bench was disinfected with 70% isopropyl alcohol. Mice
were anesthetized with 1-3% isoflourane gas in oxygen at a flow rate between 0.81.2 l·min-1. The hair on the anterior hindlimb was depilated and the underlying skin
disinfected with Nolvasan. The animal was then placed supine on a heated surgical stage
and a rectal probe thermometer was inserted to maintain internal body temperature at
35oC.
An incision was made in the medial aspect of the hindlimb and extended
proximally to the abdominal wall. Phosphate buffered saline (PBS) was applied to the
surgical site throughout the procedure to prevent tissue desiccation. The connective tissue
was blunt dissected and the epigastric fat pad was repositioned medially using a retractor
to expose the ligation site. At the ligation site, S&T forceps were used to separate the
nerve from the femoral artery-vein pair and #5/45 Dumont forceps were used to separate
15

the vein from the artery. The femoral artery was ligated distal to the epigastric branch and
proximal to the popliteal branch (Figure 5) using polypropylene suture. The contralateral
hindlimb was un-operated for control.

A

B

Site of Ligation

Figure 5: Femoral Ligation Procedure and Blood Flow Path. A) Normal blood
flow in a hindlimb. B) Site of ligation (X) and consequent blood flow pathway
through gracilis collateral network.
Intravital Microscopy
Intravital microscopy was used to assess vasodilation of the collateral stem artery
7 days following femoral artery ligation. Mice were anesthetized and prepared as
discussed in the previous section. An incision was made in the hindlimb and the
epigastric fat pad was resected using a heat cautery. Plastic wrap was placed over the
exposed tissue to prevent desiccation and the profunda femoris artery was given 30
minutes to reach a stable resting diameter.
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A

B

Figure 6: Intravital Microscopy Preparation. A) Experimental set-up during day7 procedure. B) Exposed hindlimb on mouse, images of the profunda femoris were
taken with an intravital microscope.

An intravital microscope (Olympus BXFM) with a 5x objective and QCapture
Imaging software was used to capture images of the profunda femoris artery after the
initial 30 min equilibration period at rest, and following maximal vasodilation (Figure 6).
Next, vasodilators, sodium nitroprusside (SNP, 10-3) and papaverine (10-2), were applied
to the profunda femoris artery and left to maximally dilate the artery for 5 minutes before
another set of images was taken on both the ligated and control hindlimbs.
Sample Fixation and Processing
After intravital imaging, tissues of interest were perfusion fixed. Briefly, a
catheter was inserted into the left ventricle through a thoracotomy, and the
cardiovascular system was perfused with 10mL PBS, 5mL 4% paraformaldehyde
(PFA), and 10mL PBS using a syringe pump at 4 ml⋅min-1 to maintain the
cylindrical, in situ geometry of the profunda femoris artery. During the perfusion,
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SNP and papaverine were periodically superfused to both hindlimbs to ensure the
profunda femoris retained maximum diameter during perfusion fixation.
Following perfusion fixation, the gracilis muscle and profunda femoris artery
were resected and post-fixed in 4% PFA overnight 4oC before rinsing with PBS and
stored at 4oC prior to staining.
An antibody solution was prepared containing 1:200 1A4 clone (alpha-smooth
muscle actin, Cy3 conjugate) in 0.1% saponin (in PBS) and 2% BSA, Bovine Serum
Albumin (in PBS). Samples were removed from storage and placed into individual wells
of a culture plate with 0.3mL of antibody solution and incubated for 7 days at 4oC. After
incubation, the samples were washed in 0.1% saponin in PBS and covered with foil for
20 minutes; this process was repeated 3 times. The samples were then placed in plain
PBS for 30 minutes before preparing for depression slide mounting. One to two droplets
of 50/50 PBS and Glycerol were placed onto each depression slide using a transfer
pipette and each sample was placed onto a slide, covered with cover glass, sealed with
clear nail polish to prevent tissue desiccation, and stored at 4oC covered in foil until
imaging.
Confocal Microscopy
Images of the profunda femoris artery were captured with a confocal
microscope at 40x oil immersion objective using Fluoview Viewer (FV10-ASW 4.1)
software using the Texas Red filter for light emission. The profunda artery was
imaged at the collateral stem, just proximal to the collateral branch and light power
was adjusted individually per sample to optimize brightness and SMC clarity as well
as minimize light saturation. A z-stack with 1μm slices was captured for
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approximately half the circumference of each artery setting the anterior portion of
the artery as the top of the z-stack and extending towards the posterior side. See
APPENDIX D.
Image Analysis
ImageJ was used to measure vessel diameter at rest and at maximum dilation
from the intravital images. ImageJ was also used to merge the z-stacks of the
profunda femoris into 3-D reconstructions to then create a 2-D image, and from
these images, average smooth muscle cell overlap between the individual cells could
be measured. SMC overlap was calculated by measuring all of the observable
overlaps between cells to compute an average; the average length of the SMCs was
also measured from these images.
Several considerations were made for measuring SMC length including
attempting to rotate the 3-D reconstruction of the vessel to measure the length of
each cell individually, ultimately however, a formula from previous studies was
chosen to calculate the average smooth muscle cell length using a 2-D image view.
To calculate average SMC length in a single viewing plane several assumptions must
be made [19]:

1.

The vessels are fully dilated and are cylindrical in shape.

2.

There is only one layer of SMCs on the vessel.

3.

The SMCs have only two end points.
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4.

There are two visible types of cells: “wrap” cells, which extend
across the entire visible portion of the vessel, and “taper” cells,
which partially extend the visible portion of the vessel (Figure 7).

Figure 7: Confocal microscopy view of SMCs. 1) Wrap cell extends across
entire visible portion of the artery. 2) Taper cell partially extends across
visible portion of the artery (40x).

Average smooth muscle cell length was calculated based on a formula used in
previous studies [18, 19], which uses statistical patterns of smooth muscle cell
orientation to calculate average smooth muscle cell lengths using a single view of an
image.
For each 3-D reconstruction, a 100μm length of artery was delineated for
measurement. Average smooth muscle cell length for each vessel was determined
using the following equation [18, 19]:

  4
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/

where Lc is average SMC length; Rv is the radius of the artery; F is the fraction of the
vessel circumference that measurements were made; Sw is the number of wrap
cells; St is the length of all tapered cells combined and divided by the length of a
single wrap cell; and Tv is the number of taper cells.
Statistical Analysis
Differences in the profunda femoris artery at rest and maximum dilation as well as
differences in SMC overlap and length between the ligated and control limbs were
determined using a student t-test. A p-value of less than 0.05 determined statistical
significance. Data are presented as bar graphs for visual comparison.
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RESULTS
The goal of this study was to test the hypothesis that smooth muscle cell,
SMC, mechanoadaptation occurs during outward remodeling of the collateral stem
following an upstream occlusion. The first objective was to measure the profunda
femoris artery diameter in vivo to confirm that the vessel outwardly remodeled and
exhibited impaired vasodilation at day-7 following occlusion.
Diameter
As expected based on previous work, both resting and maximally dilated
diameters were greater in the profunda femoris artery from the ligated hindlimb
than the control hindlimb, 72.7 ± 4.3μm vs. 51.2 ± 3.1μm, respectively (p<0.05,
Figure 8) for resting diameter, and 121.6 ± 2.6μm vs. 109.1 ± 3.4μm, respectively
(p<0.05, Figure 8) for maximally dilated diameter. Also as predicted, the percent
change in diameter from resting to maximum dilation was greater in the profunda
femoris artery from control hindlimb than the ligated hindlimb, 117.1 ± 14.1% vs.
69.3 ± 7.6%, respectively (p<0.05, Figure 8).
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B
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*

*

D

*

Figure 8: Profunda Femoris Diameter. A) Image of profunda femoris at resting
diameter. B) Image of profunda femoris at maximally dilated diameter. C) Vessel
diameter before and after dilation on control and ligated limbs. D) Percent change in
vessel diameter from resting to maximum dilation, n=6; *p<0.05.
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SMC Overlap and Length - Mechanoadaptation
Mechanoadaptation is expected to occur during the outward remodeling
process because based on previous studies, SMC proliferation does not occur.
The SMC overlap in the ligated hindlimb was shorter than the SMC overlap in the
control hindlimb, 43.8 ± 1.4μm vs. 50.5 ± 1.9μm, respectively (p<0.05, Figure 9).
Smooth muscle length was longer in the ligated hindlimb than in the control limb,
248.9 ± 13.1μm vs 205 ± 9.6μm, respectively, (p<0.05, Figure 10).

A

Figure 9: Smooth Muscle Cell Overlap. A) Overlap of two smooth muscle cells
denoted in blue (40x). B) Average SMC overlap in the profunda femoris artery in the
control and ligated hindlimbs, n=6; *p<0.05.
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Figure 10: Smooth Muscle Cell Length. Average smooth muscle cell length in the
profunda femoris artery in the ligated and control hindlimbs, n=6; *p<0.05.
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DISCUSSION
Patients with PAOD experience intermittent claudication, which may be
explained by impaired vasodilation, therefore, restoring vasodilation is a potential
method to alleviate symptoms. In animal models, impaired vasodilation in the stem
of the collateral network can be attributed to smooth muscle cell dysfunction [16]. It
has been previously established that smooth muscle cell, SMC, proliferation does not
occur in the collateral stem and therefore is not the cause of the impaired
vasodilation. To further investigate the cause of the impaired vasodilation, the goal
of the study was to test the hypothesis that the vascular smooth muscle cells in the
collateral stem artery underwent mechanoadaptation, or the reorientation of the
cells in response to a mechanical stimulus.
The first step to test this hypothesis was to reaffirm that outward remodeling
and impaired vasodilation occurred in the collateral stem following an upstream
arterial occlusion by measuring the diameters of the profunda femoris artery, the
collateral stem, in vivo at rest and at maximum dilation. We found that the ligated
hindlimb exhibited a larger diameter at rest and at maximum dilation than the
control, suggesting that outward remodeling had occurred. However, the percent
change in the diameter from rest to maximum dilation was larger in the control
hindlimb, indicating that vasodilation was impaired in the ischemic hindlimb.
Having confirmed that vasodilation was impaired; the second objective was
to measure the lengths and overlaps of the individual smooth muscle cells in the
profunda femoris artery to determine whether mechanoadaptation had occurred. It
was found that SMCs had less overlap in the ligated hindlimb than the control. It
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was also found that SMCs had a longer average cell length in the ligated hindlimb.
These findings suggest that the SMCs of the collateral stem in the ischemic hindlimb
have undergone mechanoadaptation.
The results from this study indicate that there is a correlation between
impaired vasodilation and SMC mechanoadaptation occurrence in the collateral
stem artery. We want to further investigate whether mechanoadaptation is both
sufficient and necessary for vasodilation impairment. One way to determine
whether it is necessary is to block mechanoadaptation from occurring after femoral
artery ligation. One possible method for this is to use endothelial nitric oxide
synthase (eNOS) inhibitors to prevent outward remodeling post-ligation. It is
believed that eNOS plays a role in collateral remodeling because an increase in fluid
shear stress activates eNOS and causes vascular smooth muscle relaxation in
arteries, this is also known as flow-mediated dilation which, when chronic, leads to
outward remodeling of the vessel [20]. It is of interest to inhibit eNOS and therefore
block outward remodeling to determine whether vasodilation under these
conditions exhibits impairment.
PAOD patients with pre-existing collaterals have a better prognosis than
those who do not. In this study, C57BL/6 mice, which have pre-existing collaterals,
were studied. A further experiment would be follow the same protocol using Balb/c
mice, which have fewer pre-existing collaterals and less collateral remodeling [21],
to see whether similar effects in smooth muscle cell mechanoadaptation are
observed. This would be a useful study to complete to better understand how
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different collateral anatomies react to an arterial occlusion because there is
evidence that collateral density and remodeling varies among humans [21].
When making conclusions and interpretations from this data, it is important
to consider that there were limitations in this study. In calculating SMC length, it
was assumed that all vessels were perfectly cylindrical. Although the vessels might
not be perfectly cylindrical, several actions were taken to address this including
using perfusion fixation to maintain the cylindrical shape and using depression
slides to mount the samples to prevent the arteries from being pressed and
misshapen between the glass. It is believed that these actions aided in reducing the
variability and error.
Further understanding of impaired vasodilation will lead to greater
understanding of intermittent claudication and PAOD, which affects millions of
Americans. Investigating smooth muscle cell orientation, which may play a role in
impaired vasodilation, leads us to gain a better insight of the disease in the hopes of
creating an effective treatment in the future.
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APPENDIX A
Confocal Images of the Profunda Femoris Artery
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APPENDIX B
Femoral Ligation Protocol

34

APPENDIX C
Perfusion Fixation Protocol
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APPENDIX D
Confocal Imaging Protocol
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